• Boracay Hotels
• Cebu Hotels
• Free Articles Submissions

Bali Hotels

Web Related Articles

• Tamoxifen: Risk of Rare Second Breast Cancer?

Breast cancer patients who take the drug tamoxifen for five or more years may be at increased risk of developing a rare but aggressive breast cancer in their opposite breast, but tamoxifen use shouldn't change, researchers report....

• Tamoxifen May Cut Lung Cancer Deaths

Tamoxifen, the medication long used to prevent the growth of breast cancer tumors, also appears to reduce the risk of dying from lung cancer, research suggests....

• Tamoxifen, Evista Prevent Breast Cancer

Updated results from a large breast cancer prevention trial confirm that both the old standby tamoxifen and the osteoporosis drug Evista can substantially cut the risk of developing breast cancer in high-risk postmenopausal women....

• Drug May Be New Option to Cut Breast Cancer Risk

Women over age 60 can safely take an estrogen-lowering drug to reduce their risk of getting breast cancer, a new study shows....

• Breast Cancer Drug Eribulin Extends Survival

The new breast cancer drug eribulin (Halaven) extends survival two and a half months longer than other therapies for advanced breast cancer, researchers report....

• Carriers of Breast Cancer Gene at Risk of Second Cancer

Women who have been successfully treated for cancer in one breast and who carry the BRCA1 or BRCA2 cancer gene are at increased risk for developing cancer in their other breast....

• Sea Sponge Drug May Fight Breast Cancer

A drug derived from sea sponges extended the lives of breast cancer patients whose cancer had come back -- despite as many as five rounds of chemotherapy -- by an average of two and a half months....

• Herceptin: Long-Term Benefits for Breast Cancer

High-risk breast cancer patients continue to derive benefits from the drug Herceptin even four years after stopping treatment, but questions remain about the biologic therapy’s safety when given with chemotherapy....

• Nexavar May Treat Advanced Breast Cancer

Adding the cancer drug Nexavar to standard chemotherapy significantly extends the time until advanced breast cancer progresses, researchers report....

• Drug Combo Extends Life With Advanced Breast Cancer

For the first time, a drug treatment has been shown to extend the lives of women with metastatic breast cancer after Herceptin alone failed....

• Targeted Breast Cancer Drug Shrinks Tumors

A new targeted cancer drug called T-DM1 has been shown to shrink tumors in women with metastatic breast cancer after an average of seven other drugs, including Herceptin, failed....

• Tamoxifen Gives 15-Year Breast Cancer Protection

Five-year tamoxifen treatment -- with or without chemotherapy -- cuts a woman's 15-year risk of breast-cancer death by about a third, long-term data show....

• Breast Cancer Death Rates Decline

Fewer women are dying from breast cancer today than ever before, and this is largely due to advances in screening and treatment. Poorer women, however, are seeing a slower and later decline in their risk of dying from breast cancer in part because they don’t have as much access to these life-saving advances.Fewer women are dying from breast cancer today than ever before, and this is largely...

• Radiation Plus Surgery Cuts Risk of Breast Cancer Return

New research shows that adding radiation therapy to breast-conserving surgery halves the chance that cancer will come back and reduces the risk of dying from breast cancer, when compared to the breast-conserving surgery alone....

• Radiation Cuts Risk of Breast Cancer Return

Radiation therapy after breast-conserving surgery cuts the risk of breast cancer returning or the risk of dying from the disease even more than doctors thought, researchers report....

• Experimental Drug Shrinks Breast Tumors

An experimental drug can slash the number of chemotherapy-resistant cancer stem cells in women with advanced breast cancer, curbing tumor growth, researchers report....

• Gene Predicts Tamoxifen Success in Breast Cancer

A single gene variant predicts breast-cancer survival after tamoxifen treatment. In the 46% of women with the "good" gene, tamoxifen works as well as newer drugs....

• Bone Drug Fails in Breast Cancer Study

The bone-building drug Zometa does not appear to prevent breast cancer from coming back in most women, researchers report....

• Paxil, Tamoxifen May Be a Risky Combo

Breast cancer patients who take the antidepressant Paxil at the same time as tamoxifen face an increased risk of dying from their disease, a new study shows....

• HRT Is Linked to Deaths From Lung Cancer

Hormone replacement therapy may raise women's risk of dying from lung cancer, a study shows....

• Avastin for Breast Cancer Treatment

WebMD examines the use of Avastin to treat breast cancer. Does it work? What are the risks? Costs? Find out what you need to know....

• FDA OKs Drug for Cancer Patients With Weakened Bones

The FDA has approved the osteoporosis drug Prolia as a treatment for some breast and prostate cancer patients whose bones have been weakened by certain hormone therapies for cancer....

• FDA Panel Opposes Avastin for Breast Cancer

An FDA panel has recommended that the drug Avastin should no longer be sold as a treatment for breast cancer....

• FDA Panel Opposes Avastin for Breast Cancer

An FDA panel has recommended that the drug Avastin should no longer be sold as a treatment for breast cancer....

• FDA Panel Opposes Avastin for Breast Cancer

An FDA panel has recommended that the drug Avastin should no longer be sold as a treatment for breast cancer....

• FDA Panel Opposes Avastin for Breast Cancer

An FDA panel has recommended that the drug Avastin should no longer be sold as a treatment for breast cancer....

• FDA Mulls Fate of Avastin as Breast Cancer Drug

The FDA is hearing testimony from doctors and patients about whether it should reconsider a decision to withdraw approval of Avastin as a treatment for advanced breast cancer....

• FDA Mulls Fate of Avastin as Breast Cancer Drug

The FDA is hearing testimony from doctors and patients about whether it should reconsider a decision to withdraw approval of Avastin as a treatment for advanced breast cancer....